World's Best Scientists 2026 revealed!
Dario Neri

Dario Neri

Award Badge
Medicine
Switzerland
2023

D-Index & Metrics

Immunology

D-Index
111
Citations
39443
World Ranking
485
National Ranking
13

Medicine

D-Index
112
Citations
39807
World Ranking
5194
National Ranking
163

Dario Neri publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dario Neri sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 606 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dario Neri D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dario Neri sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 111 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Switzerland Leader Award

Overview

Dario Neri is affiliated with ETH Zurich in Switzerland and has an extensive research portfolio primarily situated in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans significant subfields including Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, and Organic Chemistry.

The scientist has contributed to research on topics such as Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Peptidase Inhibition and Analysis, Chemical Synthesis and Analysis, Immunotherapy and Immune Responses, Radiopharmaceutical Chemistry and Applications, and Immune Cell Function and Interaction.

Several recent papers reflect the scope and diversity of their research interests:

  • DNA-Encoded Chemical Libraries: A Comprehensive Review with Succesful Stories and Future Challenges, 2021, ACS Pharmacology & Translational Science
  • An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications, 2021, Proceedings of the National Academy of Sciences
  • Immunocytokines are a promising immunotherapeutic approach against glioblastoma, 2020, Science Translational Medicine
  • Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells, 2020, Leukemia

The scientist frequently publishes in several venues, including:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neuro-Oncology
  • Molecular Cancer Therapeutics
  • Annals of Oncology

Frequent collaborators in their research include:

  • Samuele Cazzamalli
  • Emanuele Puca
  • Roberto De Luca
  • Nicholas Favalli
  • Ettore Gilardoni

Best Publications

  • Interfering with pH regulation in tumours as a therapeutic strategy

    Dario Neri;Claudiu T. Supuran

  • Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressor by biosynthetically directed fractional 13C labeling.

    Dario Neri;Thomas Szyperski;Gottfried Otting;Hans Senn

  • Tumour vascular targeting

    Dario Neri;Roy Bicknell

  • Design and Use of a Phage Display Library: HUMAN ANTIBODIES WITH SUBNANOMOLAR AFFINITY AGAINST A MARKER OF ANGIOGENESIS ELUTED FROM A TWO-DIMENSIONAL GEL *

    Alessandro Pini;Francesca Viti;Annalisa Santucci;Barbara Carnemolla

  • Encoded self-assembling chemical libraries

    Samu Melkko;Jörg Scheuermann;Christoph E Dumelin;Dario Neri

  • Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin.

    Laura Borsi;Enrica Balza;Marco Bestagno;Patrizia Castellani

  • DNA-Encoded Chemical Libraries: A Selection System Based on Endowing Organic Compounds with Amplifiable Information.

    Dario Neri;Richard A. Lerner

  • Immunoscintigraphic Detection of the ED-B Domain of Fibronectin, a Marker of Angiogenesis, in Patients with Cancer

    Monica Santimaria;Giovanni Moscatelli;Giuseppe L. Viale;Leonardo Giovannoni

  • Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform.

    Dario Neri;Barbara Carnemolla;Ahuva Nissim;Alessandra Leprini

  • Fibronectin as target for tumor therapy.

    Manuela Kaspar;Luciano Zardi;Dario Neri

  • Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

    Barbara Carnemolla;Laura Borsi;Enrica Balza;Patrizia Castellani

  • A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo.

    Alessandra Villa;Eveline Trachsel;Manuela Kaspar;Christoph Schliemann

  • Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

    C. Halin;S. Rondini;F. Nilsson;A. Berndt

  • A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors.

    Nikolaus Krall;Francesca Pretto;Willy Decurtins;Gonçalo J. L. Bernardes;Gonçalo J. L. Bernardes;Gonçalo J. L. Bernardes

  • Selective targeted delivery of TNFα to tumor blood vessels

    Laura Borsi;Enrica Balza;Barbara Carnemolla;Francesca Sassi

  • Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis.

    Francesca Viti;Lorenzo Tarli;Leonardo Giovannoni;Luciano Zardi

  • The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases

    Jascha N. Rybak;Christoph Roesli;Manuela Kaspar;Alessandra Villa

  • Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice.

    Fredrik Nilsson;Hartwig Kosmehl;Luciano Zardi;Dario Neri

  • Antibody-drug conjugates: basic concepts, examples and future perspectives.

    Giulio Casi;Dario Neri

  • Recent advances in osteosarcoma.

    Sander M Botter;Dario Neri;Bruno Fuchs

  • Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C.

    Simon S. Brack;Michela Silacci;Manfred Birchler;Dario Neri

Frequent Co-Authors

Luciano Zardi
Luciano Zardi ETH Zurich
Greg Winter
Greg Winter University of Cambridge
Giovanni Neri
Giovanni Neri Catholic University of the Sacred Heart
Gonçalo J. L. Bernardes
Gonçalo J. L. Bernardes University of Cambridge
Kurt Wüthrich
Kurt Wüthrich ETH Zurich
Michael Detmar
Michael Detmar ETH Zurich
Raffaella Giavazzi
Raffaella Giavazzi Mario Negri Institute for Pharmacological Research
Markus G. Manz
Markus G. Manz University of Zurich
Claus Garbe
Claus Garbe University of Tübingen
Christian Jung
Christian Jung Kiel University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, related healthcare degrees offer valuable pathways to complement and enhance your expertise. Nursing is a common and practical choice, with many students exploring the best online RN programs for non nurses. These programs allow individuals without a nursing background to transition smoothly into the field, opening doors to patient care roles that rely heavily on immunological knowledge.

Accelerated nursing programs also serve as an excellent option for those looking to fast-track their nursing career. The easiest ABSN to get into can make this advanced degree more accessible and affordable, allowing you to quickly gain clinical and theoretical skills that link closely with immunology practices.

For those seeking entry-level positions, programs like the LPN schools easy to get into offer straightforward paths into licensed practical nursing. This foundational role can provide hands-on experience with patient immune responses, an asset in immunology-related fields.

Advancing your career further is possible with specialized programs such as the easiest online nurse practitioner programs. These programs equip nurses with advanced clinical expertise, including immunological assessments, expanding both career opportunities and contributions to healthcare research and practice.

Best Scientists Citing Dario Neri

Trending Scientists

Recently Published Articles